[1] MALHI G S,MANN J J.Depression[J].Lancet,2018,392(10161):2299-2312.
[2] QIN D D,RIZAK J,FENG X L,et al.Prolonged secretion of cortisol as a possible mechanism underlying stress and depressive behaviour[J].Sci Rep,2016,6:30187.
[3] SALVLAT-PUJOL N,LABAD J,URRETAVIZCAYA M,et al.Hypothalamic-pituitary-adrenal axis activity and cognition in major depression:the role of remission status[J].Psychoneuroendocrinology,2017,76:38-48.
[4] SORGDRAGER F,DOORNBOS S,PENNINX B,et al.The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls[J].J Affect Disord,2017,222:32-39.
[5] ZHONG X,NING Y,GU Y,et al.A reliable global cognitive decline and cortisol as an associated risk factor for patients with late-life depression in the short term:a 1-year prospective study[J].J Affect Disord,2018,240:214-219.
[6] MILLER A H,MALETIC V,RAISON C L.Inflammation and its discontents:the role of cytokines in the pathophysiology of major depression[J].Biol Psychiatry,2009,65(9):732-741.
[7] LEONARD B E.Inflammation and depression:a causal or coincidental link to the pathophysiology?[J].Acta Neuropsychiatr,2018,30(1):1-16.
[8] SEO J S,WEI J,QIN L,et al.Cellular and molecular basis for stress-induced depression[J].Mol Psychiatry,2017,22(10):1440-1447.
[9] CATTANEO A,GENNARELLI M,UHER R,et al.Candidate genes expression profile associated with antidepressants response in the GENDEP study:differentiating between baseline'predictors'and longitudinal'targets'[J].Neuropsychopharmacology,2013,38(3):377-385.
[10] KOHLER C A,FREITAS T H,MAES M,et al.Peripheral cytokine and chemokine alterations in depression:a meta-analysis of 82 studies[J].Acta Psychiatr Scand,2017,135(5):373-387.
[11] KOHLER O,KROGH J,MORS O,et al.Inflammation in depression and the potential for anti-inflammatory treatment[J].Curr Neuropharmacol,2016,14(7):732-742.
[12] MARTIN-HERNANDEZ D,CASO J R,JAVIER M J,et al.Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression:effect of antidepressants[J].J Neuroinflammation,2018,15(1):251.
[13] WIEDLOCHA M,MARCINOWICZ P,KRUPA R,et al.Effect of antidepressant treatment on peripheral inflammation markers-a meta-analysis[J].Prog Neuropsychopharmacol Biol Psychiatry,2018,80(Pt C):217-226.
[14] KÖHLER-FORSBERG O,LYDHOLM C N,HJORTHOJ C,et al.Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms:meta-analysis of clinical trials[J].Acta Psychiatrica Scandinavica,2019,139:404-419.
[15] BAI S,GUO W,FENG Y,et al.Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder:a systematic review and meta-analysis of randomised controlled trials[J].J Neurol Neurosurg Psychiatry,2020,91(1):21-32.
[16] VOGELZANGS N,DUIVIS H E,BEEKMAN A T,et al.Association of depressive disorders,depression characteristics and antidepressant medication with inflammation[J].Transl Psychiatry,2012,2:e79.
[17] SVENNINGSSON P,GREENGARD P.p11(S100A10)——an inducible adaptor protein that modulates neuronal functions[J].Curr Opin Pharmacol,2007,7(1):27-32.
[18] SVENNINGSSON P,KIM Y,WARNER-SCHMIDT J,et al.p11 and its role in depression and therapeutic responses to antidepressants[J].Nat Rev Neurosci,2013,14(10):673-680.
[19] SEO M K,LEE J G,PARK S W.Effects of escitalopram and ibuprofen on a depression-like phenotype induced by chronic stress in rats[J].Neurosci Lett,2019,696:168-173.
[20] ANISMAN H,DU L,PALKOVITS M,et al.Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects[J].J Psychiatry Neurosci,2008,33(2):131-141.
[21] ZHANG L,SU T P,CHOI K,et al.P11(S100A10) as a potential biomarker of psychiatric patients at risk of suicide[J].J Psychiatr Res,2011,45(4):435-441.
[22] SVENNINGSSON P,CHERGUI K,RACHLEFF I,et al.Alterations in 5-HT1B receptor function by p11 in depression-like states[J].Science,2006,311(5757):77-80.
[23] WARNER-SCHMIDT J L,CHEN E Y,ZHANG X,et al.A role for p11 in the antidepressant action of brain-derived neurotrophic factor[J].Biol Psychiatry,2010,68(6):528-535.
[24] WARNER-SCHMIDT J L,VANOVER K E,CHEN E Y,et al.Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans[J].Proc Natl Acad Sci U S A,2011,108(22):9262-9267.
[25] LEE K W,WESTIN L,KIM J,et al.Alteration by p11 of mGluR5 localization regulates depression-like behaviors[J].Mol Psychiatry,2015,20(12):1546-1556.
[26] TSAI S J.The P11,tPA/plasminogen system and brain-derived neurotrophic factor:Implications for the pathogenesis of major depression and the therapeutic mechanism of antidepressants[J].Med Hypotheses,2007,68(1):180-183.
[27] HEPGUL N,CATTANEO A,ZUNSZAIN P A,et al.Depression pathogenesis and treatment:what can we learn from blood mRNA expression?[J].BMC Med,2013,11:28.
[28] SU T P,ZhANG L,ChUNG M Y,et al.Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders[J].J Psychiatr Res,2009,43(13):1078-1085.
[29] GREEN H,ZHANG X,TIKLOVA K,et al.Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease[J].Proc Natl Acad Sci U S A,2017,114(10):2735-2740.
[30] ZHANG L,LI H,SU T P,et al.p11 is up-regulated in the forebrain of stressed rats by glucocorticoid acting via two specific glucocorticoid response elements in the p11 promoter[J].Neuroscience,2008,153(4):1126-1134.
[31] SVENNINGSSON P,BERG L,MATTHEWS D,et al.Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram[J].Mol Psychiatry,2014,19(9):962-964.
[32] VAN CALKER D,SERCHOV T,NORMANN C,et al.Recent insights into antidepressant therapy:distinct pathways and potential common mechanisms in the treatment of depressive syndromes[J].Neurosci Biobehav Rev,2018,88:63-72.
[33] PEREZ-CABALLERO L,PEREZ-EGEA R,ROMERO-GRIMALDI C,et al.Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs[J].Mol Psychiatry,2014,19(5):607-614.
[34] SAHA R N,LIU X,PAHAN K.Up-regulation of BDNF in astrocytes by TNF-alpha:a case for the neuroprotective role of cytokine[J].J Neuroimmune Pharmacol,2006,1(3):212-222.
[35] ANISMAN H,GIBB J,HAYLEY S.Influence of continuous infusion of interleukin-1beta on depression-related processes in mice:corticosterone,circulating cytokines,brain monoamines,and cytokine mRNA expression[J].Psychopharmacology,2008,199(2):231-244.
[36] GUO J,ZHANG W,ZHANG L,et al.Probable involvement of p11 with interferon alpha induced depression[J].Sci Rep,2016,6:17029.
[37] SONG C,ZHANG Y,DONG Y.Acute and subacute IL-1beta administrations differentially modulate neuroimmune and neurotrophic systems:possible implications for neuroprotection and neurodegeneration[J].J Neuroinflammation,2013,10:59.
[38] BRKIC Z,FRANAIJIA E,PETROVIC Z,et al.Distinct modifications of hippocampal glucocorticoid receptor phosphorylation and FKBPs by lipopolysaccharide in depressive female and male rats[J].J Psychopharmacol,2017,31(9):1234-1249.
[39] CAO Z Y,LIU Y Z,LI J M,et al.Glycyrrhizic acid as an adjunctive treatment for depression through anti-inflammation:a randomized placebo-controlled clinical trial[J].J Affect Disord,2020,265:247-254.
[40] KOHLER O,PETERSEN L,MORS O,et al.Inflammation and depression:combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes[J].Brain Behav,2015,5(8):e338. |
